# Bupivacaine Hydrochloride, Epinephrine Bitartrate Injection: FDA shortage status > FDA source status only. Nationwide status is not local pharmacy inventory. This page does not provide medical, treatment, substitution, or dosing advice. - Derived status: current - Source statuses: Current - FDA package records: 20 - Latest FDA row update: 08/07/2026 - Retrieved: 2026-08-22T15:54:11+00:00 ## FDA package and manufacturer records - Fresenius Kabi USA, LLC — Sensorcaine, Injection, 2.5 mg/1 mL; .005 mg/1 mL (NDC 63323-461-57) — FDA availability: Available — updated: 08/04/2026 - Fresenius Kabi USA, LLC — Sensorcaine, Injection, 2.5 mg/1 mL; .005 mg/1 mL (NDC 63323-468-17) — FDA availability: Available — updated: 08/04/2026 - Fresenius Kabi USA, LLC — Sensorcaine, Injection, 2.5 mg/1 mL; .005 mg/1 mL (NDC 63323-468-37) — FDA availability: Unavailable — updated: 08/04/2026 - Fresenius Kabi USA, LLC — Sensorcaine, Injection, 5 mg/1 mL; .005 mg/1 mL (NDC 63323-462-17) — FDA availability: Available — updated: 08/04/2026 - Fresenius Kabi USA, LLC — Sensorcaine, Injection, 5 mg/1 mL; .005 mg/1 mL (NDC 63323-462-31) — FDA availability: Unavailable — updated: 08/04/2026 - Fresenius Kabi USA, LLC — Sensorcaine, Injection, 5 mg/1 mL; .005 mg/1 mL (NDC 63323-462-37) — FDA availability: Available — updated: 08/04/2026 - Fresenius Kabi USA, LLC — Sensorcaine, Injection, 5 mg/1 mL; .005 mg/1 mL (NDC 63323-463-57) — FDA availability: Available — updated: 08/04/2026 - Fresenius Kabi USA, LLC — Sensorcaine, Injection, 7.5 mg/1 mL; .005 mg/1 mL (NDC 63323-460-37) — FDA availability: Available — updated: 08/04/2026 - Hospira, Inc., a Pfizer Company — Bupivacaine Hydrochloride And Epinephrine, Injection, 25 mg/10 mL (2.5 mg/mL) (NDC 0409-9042-01) — FDA availability: Unavailable — updated: 08/07/2026 - Hospira, Inc., a Pfizer Company — Bupivacaine Hydrochloride And Epinephrine, Injection, 250 mg/50 mL (5 mg/mL) (NDC 0409-9046-01) — FDA availability: Unavailable — updated: 08/07/2026 - Hospira, Inc., a Pfizer Company — Bupivacaine Hydrochloride And Epinephrine, Injection, 50 mg/10 mL (5 mg/mL) (NDC 0409-9045-01) — FDA availability: Unavailable — updated: 08/07/2026 - Hospira, Inc., a Pfizer Company — Bupivacaine Hydrochloride And Epinephrine, Injection, 75 mg/30 mL (2.5 mg/mL) (NDC 0409-9042-17) — FDA availability: Unavailable — updated: 08/07/2026 - Hospira, Inc., a Pfizer Company — Bupivacaine Hydrochloride and Epinephrine, Injection, 125 mg/50 mL (2.5 mg/mL) (NDC 0409-9043-01) — FDA availability: Unavailable — updated: 08/07/2026 - Hospira, Inc., a Pfizer Company — Bupivacaine Hydrochloride and Epinephrine, Injection, 150 mg/30 mL (5 mg/mL) (NDC 0409-9045-17) — FDA availability: Unavailable — updated: 08/07/2026 - Hospira, Inc., a Pfizer Company — Marcaine With Epinephrine, Injection, Marcaine with Epinephrine 1:200,000 as the bitartrate 125 mg/50 mL (2.5 mg/mL 1:200,000) (NDC 0409-1752-50) — FDA availability: Available — updated: 08/07/2026 - Hospira, Inc., a Pfizer Company — Marcaine With Epinephrine, Injection, Marcaine with Epinephrine 1:200,000 as the bitartrate 150 mg/30 mL (5 mg/mL 1:200,000) (NDC 0409-1749-29) — FDA availability: Available — updated: 08/07/2026 - Hospira, Inc., a Pfizer Company — Marcaine With Epinephrine, Injection, Marcaine with Epinephrine 1:200,000 as the bitartrate 25 mg/10 mL (2.5 mg/mL 1:200,000) (NDC 0409-1746-10) — FDA availability: Available — updated: 08/07/2026 - Hospira, Inc., a Pfizer Company — Marcaine With Epinephrine, Injection, Marcaine with Epinephrine 1:200,000 as the bitartrate 250 mg/50 mL (5 mg/mL 1:200,000) (NDC 0409-1755-50) — FDA availability: Available — updated: 08/07/2026 - Hospira, Inc., a Pfizer Company — Marcaine With Epinephrine, Injection, Marcaine with Epinephrine 1:200,000 as the bitartrate 50 mg/10 mL (5 mg/mL 1:200,000) (NDC 0409-1749-10) — FDA availability: Available — updated: 08/07/2026 - Hospira, Inc., a Pfizer Company — Marcaine With Epinephrine, Injection, Marcaine with Epinephrine 1:200,000 as the bitartrate 75 mg/30 mL (2.5 mg/mL 1:200,000) (NDC 0409-1746-30) — FDA availability: Available — updated: 08/07/2026 ## Sources and formats - [FDA openFDA source](https://api.fda.gov/drug/shortages.json) - [Canonical HTML](https://citefacts.com/shortages/bupivacaine-hydrochloride-epinephrine-bitartrate-injection) - [JSON record](https://citefacts.com/shortages/bupivacaine-hydrochloride-epinephrine-bitartrate-injection.json)